190 related articles for article (PubMed ID: 10606511)
1. Crystal structure of eosinophil cationic protein at 2.4 A resolution.
Boix E; Leonidas DD; Nikolovski Z; Nogués MV; Cuchillo CM; Acharya KR
Biochemistry; 1999 Dec; 38(51):16794-801. PubMed ID: 10606511
[TBL] [Abstract][Full Text] [Related]
2. The crystal structure of eosinophil cationic protein in complex with 2',5'-ADP at 2.0 A resolution reveals the details of the ribonucleolytic active site.
Mohan CG; Boix E; Evans HR; Nikolovski Z; Nogués MV; Cuchillo CM; Acharya KR
Biochemistry; 2002 Oct; 41(40):12100-6. PubMed ID: 12356310
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional crystal structure of human eosinophil cationic protein (RNase 3) at 1.75 A resolution.
Mallorquí-Fernández G; Pous J; Peracaula R; Aymamí J; Maeda T; Tada H; Yamada H; Seno M; de Llorens R; Gomis-Rüth FX; Coll M
J Mol Biol; 2000 Jul; 300(5):1297-307. PubMed ID: 10903870
[TBL] [Abstract][Full Text] [Related]
4. Eosinophil cationic protein cDNA. Comparison with other toxic cationic proteins and ribonucleases.
Barker RL; Loegering DA; Ten RM; Hamann KJ; Pease LR; Gleich GJ
J Immunol; 1989 Aug; 143(3):952-5. PubMed ID: 2745977
[TBL] [Abstract][Full Text] [Related]
5. Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein.
Slifman NR; Loegering DA; McKean DJ; Gleich GJ
J Immunol; 1986 Nov; 137(9):2913-7. PubMed ID: 3760576
[TBL] [Abstract][Full Text] [Related]
6. Eosinophils, ribonucleases and host defense: solving the puzzle.
Rosenberg HF; Domachowske JB
Immunol Res; 1999; 20(3):261-74. PubMed ID: 10741866
[TBL] [Abstract][Full Text] [Related]
7. Both aromatic and cationic residues contribute to the membrane-lytic and bactericidal activity of eosinophil cationic protein.
Carreras E; Boix E; Rosenberg HF; Cuchillo CM; Nogués MV
Biochemistry; 2003 Jun; 42(22):6636-44. PubMed ID: 12779318
[TBL] [Abstract][Full Text] [Related]
8. Human eosinophil cationic protein. Molecular cloning of a cytotoxin and helminthotoxin with ribonuclease activity.
Rosenberg HF; Ackerman SJ; Tenen DG
J Exp Med; 1989 Jul; 170(1):163-76. PubMed ID: 2473157
[TBL] [Abstract][Full Text] [Related]
9. Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity.
Domachowske JB; Dyer KD; Adams AG; Leto TL; Rosenberg HF
Nucleic Acids Res; 1998 Jul; 26(14):3358-63. PubMed ID: 9649619
[TBL] [Abstract][Full Text] [Related]
10. Identification of cDNA encoding rat eosinophil cationic protein/eosinophil-associated ribonuclease.
Nittoh T; Hirakata M; Mue S; Ohuchi K
Biochim Biophys Acta; 1997 Mar; 1351(1-2):42-6. PubMed ID: 9116043
[TBL] [Abstract][Full Text] [Related]
11. Ribonuclease activity and substrate preference of human eosinophil cationic protein (ECP).
Sorrentino S; Glitz DG
FEBS Lett; 1991 Aug; 288(1-2):23-6. PubMed ID: 1715291
[TBL] [Abstract][Full Text] [Related]
12. High-resolution crystal structures of ribonuclease A complexed with adenylic and uridylic nucleotide inhibitors. Implications for structure-based design of ribonucleolytic inhibitors.
Leonidas DD; Chavali GB; Oikonomakos NG; Chrysina ED; Kosmopoulou MN; Vlassi M; Frankling C; Acharya KR
Protein Sci; 2003 Nov; 12(11):2559-74. PubMed ID: 14573867
[TBL] [Abstract][Full Text] [Related]
13. Eosinophil cationic protein and eosinophil-derived neurotoxin. Evolution of novel function in a primate ribonuclease gene family.
Rosenberg HF; Dyer KD
J Biol Chem; 1995 Sep; 270(37):21539-44. PubMed ID: 7665566
[TBL] [Abstract][Full Text] [Related]
14. Toxicity of an antitumor ribonuclease to Purkinje neurons.
Newton DL; Walbridge S; Mikulski SM; Ardelt W; Shogen K; Ackerman SJ; Rybak SM; Youle RJ
J Neurosci; 1994 Feb; 14(2):538-44. PubMed ID: 8301353
[TBL] [Abstract][Full Text] [Related]
15. Expression and purification of recombinant rat eosinophil-associated ribonucleases, homologues of human eosinophil cationic protein and eosinophil-derived neurotoxin, and their characterization.
Nakajima M; Hirakata M; Nittoh T; Ishihara K; Ohuchi K
Int Arch Allergy Immunol; 2001 Jul; 125(3):241-9. PubMed ID: 11490157
[TBL] [Abstract][Full Text] [Related]
16. Human eosinophil-derived neurotoxin: involvement of a putative non-catalytic phosphate-binding subsite in its catalysis.
Sikriwal D; Seth D; Dey P; Batra JK
Mol Cell Biochem; 2007 Sep; 303(1-2):175-81. PubMed ID: 17483910
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease.
Gleich GJ; Loegering DA; Bell MP; Checkel JL; Ackerman SJ; McKean DJ
Proc Natl Acad Sci U S A; 1986 May; 83(10):3146-50. PubMed ID: 3458170
[TBL] [Abstract][Full Text] [Related]
18. An insertion in loop L7 of human eosinophil-derived neurotoxin is crucial for its antiviral activity.
Sikriwal D; Seth D; Parveen S; Malik A; Broor S; Batra JK
J Cell Biochem; 2012 Oct; 113(10):3104-12. PubMed ID: 22581709
[TBL] [Abstract][Full Text] [Related]
19. The eosinophil ribonucleases.
Rosenberg HF
Cell Mol Life Sci; 1998 Aug; 54(8):795-803. PubMed ID: 9760988
[TBL] [Abstract][Full Text] [Related]
20. Kinetic and product distribution analysis of human eosinophil cationic protein indicates a subsite arrangement that favors exonuclease-type activity.
Boix E; Nikolovski Z; Moiseyev GP; Rosenberg HF; Cuchillo CM; Nogués MV
J Biol Chem; 1999 May; 274(22):15605-14. PubMed ID: 10336457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
